HLA-G by IHC

Alphabetical Test listing

HLA-G by IHC-12376 - Technical only, 12379 - Technical & interpretation

  
HLA-G by IHC
  
12376 - Technical only, 12379 - Technical & interpretation
  
LAB12376
LAB12379
  
Human leukocyte antigen G
  
  • All IHC stains will include a positive control tissue
  
  • HLA-G staining has been reported in up to 100% (70-100%) of choriocarcinomas, placental site trophoblastic tumors, epithelioid trophoblastic tumors, placental site nodules, and exaggerated placental sites
  • Non-trophoblastic tumors of GYN origin have been uniformly reported to be negative for HLA-G (one study 3 reported a case of cervical carcinoma which was focally positive for this marker)
  • HLA-G, CD10 and HCG may be useful in a panel to recognize intermediate trophoblastic tumors. If the differential also includes cervical carcinoma, p16 should be added to this panel
  • HLA-G has been reported to be associated with a shorter disease free survival in some breast, nasopharyngeal and thyroid carcinomas
  • This marker has also been reported in a variety of other tumors, including malignant mesotheliomas, lung cancers, renal cell carcinomas, malignant mesotheliomas, lymphomas, etc, and has not been associated with a survival difference
  
Tissue
  

Submit a formalin-fixed, paraffin-embedded tissue

  

Formalin-fixed, paraffin-embedded (FFPE) tissue block

  

FFPE tissue section mounted on a charged, unstained slide

  

Ambient (preferred)

  
  • Unlabeled/mislabeled block
  • Insufficient tissue
  • Slides broken beyond repair
  
AHL - Immunohistochemistry
  
Mo - Fr
  
1 - 2 days
  

Immunohistochemical staining and microscopic examination

  

If requested, an interpretive report will be provided

  

Specifications

  • HLA-G has been shown to be important for the escape of immunosurveillance (alloreactivity) by host T lymphocytes and NK cells
  • In normal and molar placentas, expression of HLA-G is thought to play a role in maternal tolerance towards fetal tissue
  • HLA-G appears to be exclusively expressed in intermediate trophoblast cells normal and molar pregnancies, and in choriocarcinomas
  • Thus, HLA-G is a specific marker for intermediate trophoblast in gestational trophoblastic disease

Staining pattern

  • Strong cytoplasmic staining

References

  1. Singer, G, Kurman RJ et al: HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis. Am J Surg Pathol 26(7): 914-920, 2002.
  2. Kleinberg L et al: Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma. Virchows Arch (2006) 449: 31-39.
  3. Kalhor N et al: Immunohistochemical studies of trophoblastic tumors. Am J Surg pathol 2009;33:633-638.
  
88342 - 1st stain
88341 - each additional stain
  
07/03/2017
  
10/19/2018
  
10/02/2020